Zurich, Switzerland; February 21, 2018 – On January 25, 2018, real estate investment specialists the ACRON Group extended the lease with Takeda Pharmaceuticals International AG for approximately 10,100 m² of office space to 2024 on behalf of ACRON Swiss Premium Assets AG (ASPA). In addition to extending its lease, Takeda expanded its offices by an additional 1,600 m², making it the anchor tenant occupying around 60% of the building.
The Portikon building is directly owned by ACRON Swiss Premium Assets AG (ASPA), which is still open to investment exclusively by qualified investors in Switzerland under the original terms. This offers investors an attractive opportunity to participate in a Swiss commercial real estate investment.
Takeda’s extension of the lease underscores the excellent business conditions for the company in Switzerland. With a workforce of over 30,000 employees in more than 70 countries worldwide, Takeda is Japan’s largest pharmaceuticals company. The Portikon building, which meets the Minergie-P® standard, features a spacious lobby, a centrally located, light-filled atrium, and various conference and meeting rooms. A restaurant in the building is available to employees and visitors.
The Glattpark neighborhood is situated in the town of Opfikon in the prosperous Glattal region. Opfikon is part of the vibrant and sophisticated Zurich metropolitan area. The quarter is located between Zurich-Kloten Airport and Zurich, known for its old town center and lake. Opfikon’s proximity to the airport and the lively city of Zurich is the engine for the town’s economic activity.
“The lease extension with our prominent anchor tenant Takeda confirms both the quality and the location of Portikon as a prime asset”, says Peer Bender, CEO of ACRON AG.
ACRON at a glance
ACRON AG is an initiator of real estate investments. The company was founded in 1981. All of ACRON’s real estate projects are based on a single-asset structure and are sold in Switzerland, Austria, Germany, and the United States. One focal point is investments in hotel properties, which account for 40% of the ACRON Group’s current investments. The company’s transaction volume amounted to over CHF 1.8 billion in mid-September 2017. ACRON’s clients are individual private investors and families from around the world. The ACRON Group’s headquarters are located in Zurich (Switzerland) with subsidiaries in Luxembourg, Düsseldorf (Germany), Dallas (US), and Sâo Paulo (Brazil). www.acron.ch, www.acronusa.com
CEO, ACRON AG
+41 (0)44 204 34 00
Head of Marketing, ACRON AG
+41 (0)44 204 34 00